Could cheap steroids help hearts in shock?
NCT ID NCT03773822
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether giving low doses of two steroids (hydrocortisone and fludrocortisone) helps adults with cardiogenic shock, a life-threatening condition where the heart can't pump enough blood. 380 participants received either the steroids or a placebo. The main goal was to see if the steroids increased the number of days patients could go without blood pressure support medications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- hydrocortisone and fludrocortisone (low-dose steroids)
- What this could lead to
- If it works, this could offer a simple, low-cost way to help people in cardiogenic shock recover faster and need less intensive support.
- What could go wrong
- This is a completed phase 3 trial, but results may not apply to all patients. Steroids can have side effects, and the benefit may be modest or absent.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOGENIC SHOCK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH Intercommunal de Villeneuve Saint Georges
Villeneuve-Saint-Georges, Villeneuve Saint Georges, 94190, France
-
CH Pontoise
Pontoise, 95300, France
-
CH de Marne la Vallée - Site Jossigny
Jossigny, Jossigny, 77600, France
-
CHRU Hôpitaux de Tours
Tours, 37000, France
-
CHU Lille - Institut Cœur Poumon
Lille, 59000, France
-
CHU de Nîmes
Nîmes, 30029, France
-
CHU de Strasbourg
Strasbourg, Strasbourg, 67000, France
-
CMC Ambroise Paré
Neuilly-sur-Seine, 92200, France
-
Centre Hospitalier Saint Joseph Saint Luc
Lyon, 69007, France
-
Centre cardiologique du nord saint denis
Saint-Denis, 93200, France
-
Groupe Hospitalier Paris Saint Joseph
Paris, 75014, France
-
Hopital Rangueil
Toulouse, 31400, France
-
Hôpital Ambroise Paré
Boulogne-Billancourt, Boulogne-Billancourt, 92100, France
-
Hôpital Arnaud-de-Villeneuve
Montpellier, 34090, France
-
Hôpital Bichat
Paris, 75018, France
-
Hôpital Cochin
Paris, 75014, France
-
Hôpital Henri Mondor
Paris, Île-de-France Region, France
-
Hôpital Parly II
Le Chesnay, Le Chasnay, 78150, France
-
Hôpital Privé Jacques Cartier
Massy, Massy, 91300, France
-
Hôpital européen Georges-Pompidou
Paris, 75015, France
-
Hôpitaux Universitaires Pitié Salpêtrière
Paris, 75013, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a key hormone be missing in septic shock?
- Could a simple filter tame the deadly inflammation of heart shock?
- Blood filter may tame deadly inflammation after heart attack
- Which ventilator mode is best for heart patients? a pilot study aims to find out
- Massive new registry aims to unlock secrets of deadly heart shock
- Could a simple sedation plan transform recovery for ECMO patients?